- Home
- CBUS vs JLS Comparison
CBUS vs JLS Comparison
Compare CBUS & JLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CBUS | JLS |
|---|---|---|
| Founded | 2010 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Agricultural Chemicals | Investment Managers |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 121.1M | 100.6M |
| IPO Year | 2017 | 2009 |
Fundamental Metrics
Financial Performance| Metric | CBUS | JLS |
|---|---|---|
| Price | $1.43 | $18.10 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 284.5K | 19.8K |
| Earning Date | 05-14-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.33% |
| EPS Growth | ★ 74.33 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,639,000.00 | N/A |
| Revenue This Year | $112.72 | N/A |
| Revenue Next Year | $83.18 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.09 | $17.45 |
| 52 Week High | $4.19 | $19.09 |
Technical Indicators
Market Signals| Indicator | CBUS | JLS |
|---|---|---|
| Relative Strength Index (RSI) | 46.26 | 42.92 |
| Support Level | $1.43 | $18.12 |
| Resistance Level | $1.50 | $18.78 |
| Average True Range (ATR) | 0.11 | 0.24 |
| MACD | 0.03 | -0.04 |
| Stochastic Oscillator | 68.89 | 15.64 |
Price Performance
Historical ComparisonAbout CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
About JLS Nuveen Mortgage and Income Fund
Nuveen Mortgage And Income Fund is a diversified, closed-end management investment company. The fund invests at least fifty percent of its Managed Assets in MBS, including residential MBS and commercial MBS, and up to fifty percent in non-mortgage related ABS. The Fund's investment objective is to provide a high level of current income.